• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA错配修复缺陷在人类癌症发病机制中的作用。

Role of DNA mismatch repair defects in the pathogenesis of human cancer.

作者信息

Peltomäki Päivi

机构信息

Department of Medical Genetics, University of Helsinki, Finland.

出版信息

J Clin Oncol. 2003 Mar 15;21(6):1174-9. doi: 10.1200/JCO.2003.04.060.

DOI:10.1200/JCO.2003.04.060
PMID:12637487
Abstract

The DNA mismatch repair (MMR) system is necessary for the maintenance of genomic stability. In a broad sense, all main functions of the MMR system, including the correction of biosynthetic errors, DNA damage surveillance, and prevention of recombination between nonidentical sequences serve this important purpose. Failure to accomplish these functions may lead to cancer. It is therefore not surprising that inherited defects in the MMR system underlie one of the most prevalent cancer syndromes in humans, hereditary nonpolyposis colon cancer (HNPCC). In addition, acquired defects of the same system may account for 15% to 25%, or even a higher percentage, of sporadic cancers of different organs of the "HNPCC spectrum," including the colon and rectum, uterine endometrium, stomach, and ovaries. Recent studies indicate that the MMR genes may be involved in the pathogenesis of even a broader spectrum of tumors in one way or another. An updated review of the different features of the human MMR system will be provided, with the emphasis on their implications in cancer development.

摘要

DNA错配修复(MMR)系统对于维持基因组稳定性是必需的。从广义上讲,MMR系统的所有主要功能,包括纠正生物合成错误、DNA损伤监测以及防止非同源序列之间的重组,都服务于这一重要目的。无法完成这些功能可能会导致癌症。因此,MMR系统的遗传性缺陷是人类最常见的癌症综合征之一——遗传性非息肉病性结直肠癌(HNPCC)的基础,这并不奇怪。此外,同一系统的获得性缺陷可能占“HNPCC谱系”不同器官散发性癌症的15%至25%,甚至更高比例,这些器官包括结肠和直肠、子宫内膜、胃和卵巢。最近的研究表明,MMR基因可能以某种方式参与了更广泛谱系肿瘤的发病机制。本文将对人类MMR系统的不同特征进行更新综述,重点关注它们在癌症发展中的意义。

相似文献

1
Role of DNA mismatch repair defects in the pathogenesis of human cancer.DNA错配修复缺陷在人类癌症发病机制中的作用。
J Clin Oncol. 2003 Mar 15;21(6):1174-9. doi: 10.1200/JCO.2003.04.060.
2
Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity (review).DNA错配修复基因中的突变:对DNA损伤信号传导和药物敏感性的影响(综述)
Int J Oncol. 2004 Apr;24(4):1039-47.
3
DNA mismatch repair gene mutations in human cancer.人类癌症中的DNA错配修复基因突变。
Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):775-80. doi: 10.1289/ehp.105-1470030.
4
DNA mismatch repair and cancer.DNA错配修复与癌症
Mutat Res. 2001 Mar;488(1):77-85. doi: 10.1016/s1383-5742(00)00058-2.
5
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.遗传性非息肉病性结直肠癌:诊断策略及其影响。
Evid Rep Technol Assess (Full Rep). 2007 May(150):1-180.
6
Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.遗传性非息肉病性结直肠癌的妇科表现。从遗传性疾病到散发性疾病。
Oncology (Williston Park). 2006 Jan;20(1):85-94; discussion 94-6, 100.
7
Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.遗传性非息肉病性结直肠癌患者良性和恶性肿瘤中的复制错误
Cancer Res. 1994 Apr 1;54(7):1645-8.
8
[From gene to disease; from DNA 'mismatch' repair genes to hereditary non-polyposis colorectal carcinoma].[从基因到疾病;从DNA“错配”修复基因到遗传性非息肉病性结直肠癌]
Ned Tijdschr Geneeskd. 2001 Apr 21;145(16):780-2.
9
Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer.遗传性非息肉病性结直肠癌中DNA错配修复和促凋亡基因的体细胞移码突变。
Cancer Res. 1998 Mar 1;58(5):997-1003.
10
Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer.小鼠DNA错配修复功能丧失与癌症易感性:人类遗传性非息肉病性结直肠癌的动物模型
Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):91-9. doi: 10.1002/ajmg.c.30021.

引用本文的文献

1
Exploring Auger electron-emitting radionuclides for targeted DNA damage in mismatch repair-deficient cells: a theoretical study of Rh- and I-labeled metalloinsertors.探索俄歇电子发射放射性核素用于错配修复缺陷细胞中的靶向DNA损伤:Rh和I标记的金属插入剂的理论研究
Int J Radiat Biol. 2025 Jun 20:1-8. doi: 10.1080/09553002.2025.2517328.
2
Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors.实体瘤中的错配修复缺陷与微卫星不稳定性
Int J Mol Sci. 2025 May 6;26(9):4394. doi: 10.3390/ijms26094394.
3
Increased risk of adenomatous colon polyps in patients with long-term use of proton pump inhibitors: a single-center retrospective study.
长期使用质子泵抑制剂患者患结肠腺瘤性息肉风险增加:一项单中心回顾性研究。
J Yeungnam Med Sci. 2025;42:24. doi: 10.12701/jyms.2025.42.24. Epub 2025 Jan 21.
4
Diagnostic Challenges due to a Germline Missense MSH2 Variant in a Patient With Immunotherapy-Responsive Locally Advanced Rectal Adenocarcinoma.免疫治疗反应性局部晚期直肠腺癌患者中一种生殖系错义MSH2变异导致的诊断挑战
Cancer Rep (Hoboken). 2024 Dec;7(12):e70037. doi: 10.1002/cnr2.70037.
5
Advances in Immunotherapy for Endometrial Cancer: Insights into MMR Status and Tumor Microenvironment.子宫内膜癌免疫治疗的进展:对错配修复状态和肿瘤微环境的见解
Cancers (Basel). 2024 Nov 22;16(23):3918. doi: 10.3390/cancers16233918.
6
Glioma oncogenesis in the Constitutional mismatch repair deficiency (CMMRD) syndrome.先天性错配修复缺陷(CMMRD)综合征中的胶质瘤发生
Neurooncol Adv. 2024 Jul 11;6(1):vdae120. doi: 10.1093/noajnl/vdae120. eCollection 2024 Jan-Dec.
7
Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes.基因谱分析对遗传性结直肠癌综合征手术决策的影响。
Heliyon. 2024 Jul 9;10(15):e34375. doi: 10.1016/j.heliyon.2024.e34375. eCollection 2024 Aug 15.
8
The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study.错配修复状态与 III 期结直肠癌显微镜下阳性(R1)切缘的相关性:一项回顾性队列研究。
Ann Surg Oncol. 2024 Oct;31(10):6423-6431. doi: 10.1245/s10434-024-15595-0. Epub 2024 Jun 21.
9
PMS2 amplification contributes brain metastasis from lung cancer.PMS2基因扩增促进肺癌脑转移。
Biol Proced Online. 2024 May 7;26(1):12. doi: 10.1186/s12575-024-00238-1.
10
Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family.资源匮乏国家中 CMMRD 的诊断和管理策略:突尼斯家族报告。
Fam Cancer. 2024 Nov;23(4):515-522. doi: 10.1007/s10689-024-00386-z. Epub 2024 Apr 30.